Finance

Beta
Lists
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
25,00 INR
-1,69%
(-0,43) 1D
3-июн., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
25,01 INR
High
25,95 INR
Low
24,21 INR
Mkt. cap
1,38 млд
Avg. vol.
37,41 миң
Volume
35,20 миң
P/E ratio
14,61
52-wk high
63,90 INR
52-wk low
15,20 INR
EPS
1,71 INR
No. of employees
600
Open
25,01 INR
High
25,95 INR
Low
24,21 INR
Mkt. cap
1,38 млд
Avg. vol.
37,41 миң
Volume
35,20 миң
P/E ratio
14,61
52-wk high
63,90 INR
52-wk low
15,20 INR
EPS
1,71 INR
No. of employees
600
News stories
From sources across the web
About Balaxi Pharmaceuticals Ltd
CEO-
Employees600
Founded1942
Headquarters-
SectorHealth care provider
Websitebalaxipharma.in
Last report
2026-ж., 28-май
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
736,31 млн / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
707,42 млн
561,75 млн
725,42 млн
736,31 млн
Cost of goods sold
395,60 млн
290,29 млн
417,35 млн
405,51 млн
Cost of revenue
395,60 млн
290,29 млн
417,35 млн
405,51 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
270,34 млн
259,77 млн
277,18 млн
300,41 млн
Operating expense
274,96 млн
264,62 млн
282,77 млн
306,88 млн
Total operating expenses
670,56 млн
554,91 млн
700,12 млн
712,38 млн
Operating income
36,86 млн
6,84 млн
25,30 млн
23,92 млн
Other non operating income
-17,76 млн
15,85 млн
957,00 миң
-1,00 миң
EBT including unusual items
9,03 млн
13,77 млн
16,10 млн
14,02 млн
EBT excluding unusual items
9,03 млн
13,77 млн
16,10 млн
14,02 млн
Income tax expense
6,13 млн
11,68 млн
13,05 млн
7,90 млн
Effective tax rate
67,89%
84,82%
81,05%
56,31%
Other operating expenses
-
-
-
-
Net income
2,90 млн
2,09 млн
3,05 млн
6,13 млн
Net profit margin
0,41%
0,37%
0,42%
0,83%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-10,06 млн
-8,92 млн
-10,16 млн
-9,90 млн
Net interest expenses
-10,06 млн
-8,92 млн
-10,16 млн
-9,90 млн
Depreciation and amortization charges
4,62 млн
4,84 млн
5,60 млн
6,46 млн
EBITDA
41,13 млн
11,58 млн
29,57 млн
28,20 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer